These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9838354)

  • 41. Enalapril: safe and effective therapy for posttransplant erythrocytosis.
    Gaston RS; Julian BA; Barker CV; Diethelm AG; Curtis JJ
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1029-31. PubMed ID: 8442029
    [No Abstract]   [Full Text] [Related]  

  • 42. Angiotensin II receptor antagonists: enlarging therapeutic possibilities in arterial hypertension.
    Plante GE
    Can J Cardiol; 1999 Nov; 15 Suppl F():4F-6F. PubMed ID: 10579746
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies of erythroid burst-forming units in patients with posttransplant erythrocytosis.
    Glicklich D; Kapoian T; Mian H; Greenstein S; Tellis V; Croizat H
    Transplant Proc; 1999; 31(1-2):1284-5. PubMed ID: 10083573
    [No Abstract]   [Full Text] [Related]  

  • 44. Posttransplant erythrocytosis: a possible nonerythropoietin-mediated mechanism.
    Morrone LF; Schena A; Di Paolo S; Stallone G; Schena FP
    Transplant Proc; 1997; 29(1-2):223. PubMed ID: 9122971
    [No Abstract]   [Full Text] [Related]  

  • 45. A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension.
    Hedner T; Oparil S; Rasmussen K; Rapelli A; Gatlin M; Kobi P; Sullivan J; Oddou-Stock P
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):414-7. PubMed ID: 10232502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of angiotensin-receptor antagonists on erythrocytosis after renal transplantation.
    Ducloux D; Bresson-Vautrin C; Chalopin JM
    Nephrol Dial Transplant; 1996 Aug; 11(8):1668. PubMed ID: 8856237
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term effect on hypertension of phlebotomy in posttransplant erythrocytosis.
    Spieker C; Barenbrock M; Tepel M; Zidek W
    Transplant Proc; 1992 Dec; 24(6):2742-4. PubMed ID: 1465923
    [No Abstract]   [Full Text] [Related]  

  • 48. The beneficial effect of enalapril on erythrocytosis after renal transplantation.
    Conlon PJ; Farrell J; Donohoe J; Walshe JJ
    Transplantation; 1993 Jul; 56(1):217-9. PubMed ID: 8333046
    [No Abstract]   [Full Text] [Related]  

  • 49. Losartan reduces massive proteinuria in kidney transplant patients: a pilot study.
    Domínguez-Gil B; Ortiz M; Sierra MP; Muñoz MA; Morales E; Andres A; Rodicio JL; Morales JM
    Transplant Proc; 2002 Feb; 34(1):368-9. PubMed ID: 11959331
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of angiotensin II type-1 receptor blockers on stable allograft kidneys: prospective randomized study.
    Nouri-Majalan N; Ghafari A; Moghaddasi S
    Transplant Proc; 2009 Sep; 41(7):2832-4. PubMed ID: 19765449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.
    Kassler-Taub K; Littlejohn T; Elliott W; Ruddy T; Adler E
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):445-53. PubMed ID: 9607383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
    Hernández E; Morales JM; Andrés A; Ortuño B; Praga M; Alcazar JM; Fernández G; Rodicio JL
    Transplant Proc; 1995 Aug; 27(4):2239-41. PubMed ID: 7652789
    [No Abstract]   [Full Text] [Related]  

  • 53. Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis.
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Mioni G
    Transplant Proc; 2001; 33(1-2):2038-40. PubMed ID: 11267615
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
    Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
    Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of hypertension and heart failure with AT1 receptor blockade.
    Weinberg EO; Herzig JW
    J Pak Med Assoc; 2001 Feb; 51(2):81-5. PubMed ID: 11321878
    [No Abstract]   [Full Text] [Related]  

  • 56. [Interview with the author of ELITE II. Cave: small studies of fatal illnesses].
    Pitt B
    MMW Fortschr Med; 1999 Nov; 141(47):6. PubMed ID: 10912156
    [No Abstract]   [Full Text] [Related]  

  • 57. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is losartan as effective as enalapril on posttransplant persistent proteinuria?
    Altiparmak MR; Trablus S; Apaydin S; Başar O; Sariyar M; Serdengeçti K; Erek E
    Transplant Proc; 2001; 33(7-8):3368-9. PubMed ID: 11750440
    [No Abstract]   [Full Text] [Related]  

  • 59. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II.
    Miller JA; Thai K; Scholey JW
    Kidney Int; 1999 Dec; 56(6):2173-80. PubMed ID: 10594793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.